OSL oncosil medical ltd

Ann: Appendix 4C - Quarterly Cash Flow, page-2

  1. 228 Posts.
    lightbulb Created with Sketch. 1
    Admin and corporate - from 395,000 Q1 to 566,000 Q2. (Q3 est. 500,000)
    R & D - from 318,000 Q1 to 653,000 Q2. (Q3 est. 750,000)
    Seems strange they have declared no product manufacturing and operating costs or advertising and marketing costs, for the year so far.
    Just a couple of notes from the mini up date.-
    - Many aspects of this lengthy review have now been successfully closed out.
    - Following a successful meeting in November the Company now anticipates a CE Mark determination in the next few weeks. (Those dates I posted a few days ago may be right)
    - And of course, Me Kenny is " delighted ".
    OLI
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.075(6.10%)
Mkt cap ! $16.35M
Open High Low Value Volume
$1.25 $1.25 $1.11 $45.47K 37.73K

Buyers (Bids)

No. Vol. Price($)
2 16450 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.18 585 1
View Market Depth
Last trade - 14.02pm 27/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.